Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

v3.21.2
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY - USD ($)
Total
Series A, Preferred Stock
Series B, Preferred Stock
Common Stock
Additional Paid-In Capital
Stock Payable [Member]
Retained Earnings (Accumulated Deficit)
Noncontrolling Interest
Balance, shares at Mar. 31, 2020   5,000,000 2,250 379,742,524        
Balance, amount at Mar. 31, 2020 $ (2,937,780) $ 500 $ 0 $ 37,975 $ 43,533,243 $ 0 $ (46,427,396) $ (82,101)
Issuance of common stock upon conversion, shares       37,926,239        
Issuance of common stock upon conversion, amount 226,437     $ 3,793 222,644      
Reclass of derivative liability upon conversion or redemption of related convertible debentures, amount 205,000       205,000      
Purchase of Series B Preferred shares, shares     1,250          
Purchase of Series B Preferred shares, amount 1,250,000   $ 0   1,250,000      
Beneficial conversion feature related to the Series B Preferred Shares 0       293,000   (293,000)  
Dividends payable on Series B PS (144,792)           (144,792)  
Series B PS Dividends in kind issued, shares     50          
Series B PS Dividends in kind issued, amount 56,458   $ 0   56,458      
Conversion of Series B PS to common stock, shares     (800) 33,569,730        
Conversion of Series B PS to common stock, amount 0   $ (0) $ 3,357 (3,357)      
Common stock issued in Vista Warrant settlement, shares       17,500,000        
Common stock issued in Vista Warrant settlement, amount 610,000     $ 1,750 608,250      
Reclass of warrant liability upon the cancellation of warrants under Vista Warrant settlement 90,000       90,000      
Common stock issued to consultant, shares       1,250,000        
Common stock issued to consultant, amount 61,250     $ 125 61,125      
Net loss (478,967)           (477,072) (1,895)
Balance, shares at Jun. 30, 2020   5,000,000 2,750 469,988,493        
Balance, amount at Jun. 30, 2020 (1,062,394) $ 500 $ 0 $ 47,000 46,316,363 0 (47,342,260) (83,996)
Balance, shares at Mar. 31, 2020   5,000,000 2,250 379,742,524        
Balance, amount at Mar. 31, 2020 (2,937,780) $ 500 $ 0 $ 37,975 43,533,243 0 (46,427,396) (82,101)
Common stock issued to consultant, amount 128,750              
Net loss (1,065,265)              
Balance, shares at Sep. 30, 2020   5,000,000 1,696 531,023,743        
Balance, amount at Sep. 30, 2020 (215,012) $ 500 $ (0) $ 53,103 48,638,480 0 (48,821,413) (85,682)
Balance, shares at Jun. 30, 2020   5,000,000 2,750 469,988,493        
Balance, amount at Jun. 30, 2020 (1,062,394) $ 500 $ 0 $ 47,000 46,316,363 0 (47,342,260) (83,996)
Issuance of common stock upon conversion, shares       1,014,001        
Issuance of common stock upon conversion, amount 125,736     $ 101 125,635      
Purchase of Series B Preferred shares, shares     1,250          
Purchase of Series B Preferred shares, amount 1,250,000   $ 0   1,250,000      
Beneficial conversion feature related to the Series B Preferred Shares 0   $ 0   807,000   (807,000)  
Dividends payable on Series B PS (83,960)           (83,960)  
Series B PS Dividends in kind issued, shares     65          
Series B PS Dividends in kind issued, amount 77,984       77,984      
Conversion of Series B PS to common stock, shares     (2,369) 58,521,249        
Conversion of Series B PS to common stock, amount 0   $ (0) $ 5,852 (5,852)      
Common stock issued to consultant, shares       1,500,000        
Common stock issued to consultant, amount 67,500     $ 150 67,350      
Net loss (588,193)           (588,193) (1,686)
Balance, shares at Sep. 30, 2020   5,000,000 1,696 531,023,743        
Balance, amount at Sep. 30, 2020 (215,012) $ 500 $ (0) $ 53,103 48,638,480 0 (48,821,413) (85,682)
Balance, shares at Mar. 31, 2021   5,000,000 607 560,745,180        
Balance, amount at Mar. 31, 2021 3,070,969 $ 500 $ 0 $ 56,076 56,649,491 136,000 (53,683,268) (87,830)
Issuance of common stock upon conversion, shares       1,329,246        
Issuance of common stock upon conversion, amount 421,486     $ 133 421,353      
Conversion of Series B PS to common stock, shares     (262) 3,144,000        
Conversion of Series B PS to common stock, amount 0   $ 0 $ 314 (314)      
Common stock issued to consultant, shares       125,000        
Common stock issued to consultant, amount 73,651     $ 13 48,738 24,900    
Net loss (2,562,743)           (2,562,743)  
Conversion of Series D PS to common stock, shares       428,572        
Conversion of Series D PS to common stock, amount 0   $ 0 $ 43 (43)      
Exchange of Series D PS to Series E PS (3,258,189)           (3,258,189)  
Sale of common shares and warrants for cash, less offering costs and commitment shares, shares       35,772,729        
Sale of common shares and warrants for cash, less offering costs and commitment shares, amount 17,277,123     $ 3,577 17,273,546      
Exercise of warrants related to the sale of common shares, shares       1,100,000        
Exercise of warrants related to the sale of common shares, amount 11,000     $ 110 10,890      
Beneficial conversion feature related to the Series E Preferred Shares 3,269,505       3,269,505      
Amortization of beneficial conversion feature related to Series E Preferred Shares (817,376)           (817,376)  
Redemption of Series D Preferred shares (2,534,758)           (2,534,758)  
Common shares to be issued for the acquisition of the non-controlling interest subsidiary's remaining equity (1,000,000)       (3,087,830) 2,000,000   87,830
Common shares to be issued for Patent acquisition 5,000,000         5,000,000    
Balance, shares at Jun. 30, 2021   5,000,000 345 602,644,727        
Balance, amount at Jun. 30, 2021 18,950,668 $ 500 $ 0 $ 60,266 74,585,336 7,160,900 (62,856,334) 0
Balance, shares at Mar. 31, 2021   5,000,000 607 560,745,180        
Balance, amount at Mar. 31, 2021 3,070,969 $ 500 $ 0 $ 56,076 56,649,491 136,000 (53,683,268) (87,830)
Common stock issued to consultant, amount 122,926              
Net loss (5,412,378)              
Balance, shares at Sep. 30, 2021   5,000,000 345 606,821,513        
Balance, amount at Sep. 30, 2021 19,210,511 $ 500 $ 0 $ 60,683 74,609,294 11,948,176 (67,408,142) 0
Balance, shares at Jun. 30, 2021   5,000,000 345 602,644,727        
Balance, amount at Jun. 30, 2021 18,950,668 $ 500 $ 0 $ 60,266 74,585,336 7,160,900 (62,856,334) 0
Common stock issued to consultant, shares       62,500        
Common stock issued to consultant, amount 49,275     $ 6 24,369 24,900    
Net loss (2,849,635)           (2,849,635)  
Amortization of beneficial conversion feature related to Series E Preferred Shares (1,341,948)           (1,341,948)  
Conversion of Series E PS to common stock, shares       4,114,286        
Conversion of Series E PS to common stock, amount 0     $ 411 (411)      
Revision of dividends payable on Series B Preferred Shares (See Note 2)             (182,639)  
Dividends payable on Preferred Shares             (177,586)  
Common shares to be issued for Technical and Equipment Rights Agreement 4,762,376         4,762,376    
Balance, shares at Sep. 30, 2021   5,000,000 345 606,821,513        
Balance, amount at Sep. 30, 2021 $ 19,210,511 $ 500 $ 0 $ 60,683 $ 74,609,294 $ 11,948,176 $ (67,408,142) $ 0